Copyright
©The Author(s) 2025.
World J Clin Oncol. Feb 24, 2025; 16(2): 95642
Published online Feb 24, 2025. doi: 10.5306/wjco.v16.i2.95642
Published online Feb 24, 2025. doi: 10.5306/wjco.v16.i2.95642
Figure 3 Percentage of peripheral blood lymphocytes during PRaG treatment.
The percentage of CD4+T cells and CD8+T cell subsets increased to varying degrees during PRaG treatment.
- Citation: Chen WW, Kong YH, Zhang LY. Denosumab combined with immunotherapy, radiotherapy, and granulocyte-macrophage colony-stimulating factor for the treatment of metastatic nasopharyngeal carcinoma: A case report. World J Clin Oncol 2025; 16(2): 95642
- URL: https://www.wjgnet.com/2218-4333/full/v16/i2/95642.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i2.95642